Overview
What is Global Alzheimer's Platform Foundation Inc?
Global Alzheimer's Platform Foundation Inc, based in Washington D.C., is a nonprofit organization committed to revolutionizing Alzheimer's clinical trials. Their mission is to reduce clinical testing cycle times by two years and enhance uniformity in trial populations. To achieve this, they are establishing a global trial-ready platform, comprising large, well-characterized trial-ready cohorts and a network of certified high-performance clinical trial sites. Collaborating with international organizations, the foundation fosters innovation in clinical trials and maintains open communication with initiatives under development in various countries and continents. With around 39 employees, they strive to expedite and optimize Alzheimer's research.
Official website here: www.globalalzplatform.org
Is Global Alzheimer's Platform Foundation Inc legitimate?
Global Alzheimer's Platform Foundation Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. Global Alzheimer's Platform Foundation Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Here are some key statistics you may want to consider:
Executive Compensation: $450,920
Professional Fundraising Fees: $0
Other Salaries and Wages: $2,285,037
For more financial information, click here
Official website here: www.globalalzplatform.org
What is the mission statement of Global Alzheimer's Platform Foundation Inc?
The Global Alzheimer's Platform Foundation Inc works collaboratively with international organizations sharing its goal of clinical trial innovation. The organization engages in global partnerships to coordinate efforts, share information, and maintain open dialogue with initiatives under development in various countries and continents. The mission of Global Alzheimer's Platform Foundation Inc is to establish a standing global trial-ready platform for Alzheimer's clinical trials, aiming to enhance quality, efficiency, and innovation. By building large, well-characterized trial-ready cohorts and a network of certified high-performance clinical trial sites, the foundation seeks to reduce clinical testing cycle times by two years and achieve greater uniformity in trial populations.
Official website here: www.globalalzplatform.org
Who is the CEO of Global Alzheimer's Platform Foundation Inc?
John Dwyer is the President of Global Alzheimer's Platform Foundation Inc.
Official website here: www.globalalzplatform.org
What is the revenue of Global Alzheimer's Platform Foundation Inc?
Global Alzheimer's Platform Foundation Inc's revenue in 2022 was $11,462,253.
Official website here: www.globalalzplatform.org
Who are the executives of Global Alzheimer's Platform Foundation Inc and what are their salaries?
The average compensation at Global Alzheimer's Platform Foundation Inc during 2022 was $70,153. There are 39 employees at Global Alzheimer's Platform Foundation Inc.
Here are 7 key members and their salaries:
- John Dwyer (President) [Trustee/Director]
- George Vradenburg (Chair) [Trustee/Director]
- Drew Holzapfel (Board Member) [Trustee/Director]
- Steven Paul (Board Member) [Trustee/Director]
- Neil Buckholtz (Board Member) [Trustee/Director]
- Michael Glosserman (Board Member) [Trustee/Director]
- Pascale Witz (Board Member) [Trustee/Director]
Official website here: www.globalalzplatform.org
Where can I find the form 990 for Global Alzheimer's Platform Foundation Inc?
The Global Alzheimer's Platform Foundation Inc’s most recent form 990 was submitted in 2022 and can be accessed here
Official website here: www.globalalzplatform.org
Learn more at the official website: www.globalalzplatform.org
Mission Statement of Global Alzheimer's Platform Foundation Inc
Global Alzheimer's Platform Foundation, abbreviated as GAP, collaborates with international organizations sharing its goal for innovative clinical trials in Alzheimer's disease. The organization actively engages with global partners, facilitating communication, information exchange, and coordination of efforts in various countries and continents. GAP's mission is to establish a standing global trial-ready platform, aiming to improve the quality, efficiency, and innovation in Alzheimer's clinical trials. By reducing clinical testing cycle times by two years and achieving greater uniformity in trial populations, GAP seeks to build large, well-characterized trial-ready cohorts and a network of certified high-performance clinical trial sites. This approach is designed to drive advancements in Alzheimer's research and ultimately, contribute to a better understanding and treatment of the disease.
Impact
This information is meant to be a general summary of Global Alzheimer's Platform Foundation Inc. Please take the time to review official sources before making any decisions based upon the content provided here.
Saturday, July 20, 2024
Global Alzheimer's Platform Foundation Inc's impact is focused on establishing a standing global trial-ready platform to drive quality, efficiency, and innovation in Alzheimer's clinical trials. By building large, well-characterized trial-ready cohorts and a network of certified high-performance clinical trial sites, the organization seeks to reduce clinical testing cycle times by two years and achieve greater uniformity in trial populations. This pioneering effort aims to accelerate the discovery of effective treatments for Alzheimer's disease by streamlining the clinical trial process and fostering collaboration with international partners who share similar goals for clinical trial innovation.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Assets and Liabilities:
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
CLINICAL TRIALS
Revenue
$10,575,489
Organization Details
Founding Year
2015
Phone
(301) 452-2111
Principal Officer
John Dwyer
Main Address
1101 K STREET NW Suite 400, WASHINGTON, DC, 20005
Website
www.globalalzplatform.org
NTEE Category
Code: G02 - Disease
If you are a representative of Global Alzheimer's Platform Foundation Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.